Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 14/20 | 0.80 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29859288 | 0.89 | DHODH (1.00) | DHODHMAPK1MEN1KMT2A | |
| SCHEMBL19631362 | 0.89 | DHODH (1.00) | DHODHMAPK1MEN1KMT2A | |
| SCHEMBL20836154 | 0.89 | DHODH (1.00) | DHODHMAPK1MEN1KMT2A | |
| SCHEMBL19631370 | 0.81 | DHODH (1.00) | DHODHALDH1A1HSD17B10MAPK1MEN1 | |
| SCHEMBL20956542 | 0.81 | DHODH (1.00) | DHODHALDH1A1HSD17B10MAPK1MEN1 | |
| SCHEMBL29859659 | 0.81 | DHODH (1.00) | DHODHALDH1A1HSD17B10MAPK1MEN1 | |
| SCHEMBL25613978 | 0.81 | DHODH (0.73) | DHODHALDH1A1MAPK1GSTO1CYP1A2 | |
| SCHEMBL25614126 | 0.79 | DHODH (0.71) | DHODHALDH1A1HSD17B10MAPK1HPGD | |
| SCHEMBL19631470 | 0.76 | DHODH (1.00) | DHODH | |
| SCHEMBL25613706 | 0.75 | DHODH (0.75) | DHODHALDH1A1GSTO1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | SARS1, EIF2AK2, NSUN3 | DHODH 2268/4885ALOX5 3599/4885ALDH1A1 2462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.